Drug induced parkinsonism: Symptomatic beyond 22 months.

Clicks: 268
ID: 31169
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #8 of 10 articles by views in parkinsonism & related disorders

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We report 2 cases of drug induced Parkinsonism followed longitudinally that remained symptomatic 22 and 27 months after stopping causative agents with normal dopamine ioflupane iodine-123 (DaT) single-photon emission computed tomography (SPECT) scans at 8 and 16 months.
Reference Key
randhawa2019drugparkinsonism Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Randhawa, Jaskaren;Mehanna, Raja;
Journal parkinsonism & related disorders
Year 2019
DOI
S1353-8020(19)30365-7
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.